Pharming Group N.V. (AMS:PHARM)
0.871
+0.001 (0.11%)
Mar 3, 2025, 5:37 PM CET
Pharming Group Revenue
Pharming Group had revenue of $74.85M USD in the quarter ending September 30, 2024, with 12.22% growth. This brings the company's revenue in the last twelve months to $285.75M, up 30.64% year-over-year. In the year 2023, Pharming Group had annual revenue of $245.32M with 19.30% growth.
Revenue (ttm)
$285.75M
Revenue Growth
+30.64%
P/S Ratio
2.22
Revenue / Employee
$748.02K
Employees
382
Market Cap
592.55M EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 245.32M | 39.69M | 19.30% |
Dec 31, 2022 | 205.62M | 6.75M | 3.39% |
Dec 31, 2021 | 198.87M | -13.30M | -6.27% |
Dec 31, 2020 | 212.17M | 22.79M | 12.03% |
Jan 1, 2020 | 189.39M | 54.26M | 40.15% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionPharming Group News
- 24 days ago - Pharming Technologies B.V. declares unconditional and completes the recommended cash offer to the shareholders of Abliva AB (publ) and extends the acceptance period - GlobeNewsWire
- 5 weeks ago - Pharming Group to convene Extraordinary General Meeting of Shareholders - GlobeNewsWire
- 5 weeks ago - Pharming Group Nominates Fabrice Chouraqui as New CEO and Executive Director - CEOWORLD magazine
- 5 weeks ago - Pharming Group appoints former Novartis USA President Fabrice Chouraqui as New CEO - Seeking Alpha
- 5 weeks ago - Pharming to nominate biopharmaceutical leader Fabrice Chouraqui as new Executive Director and Chief Executive Officer - GlobeNewsWire
- 2 months ago - Pharming Group offers to buy Sweden's Abliva for SEK 0.45/shr - Seeking Alpha
- 2 months ago - Pharming announces public cash offer to the shareholders of Abliva AB - GlobeNewsWire
- 2 months ago - European Biotech Pharming Group Touts Positive Data From Pivotal Pediatric Study Of FDA-Approved Immune System Disorder Drug - Benzinga